BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34204408)

  • 41. A spectroscopic liquid biopsy for the earlier detection of multiple cancer types.
    Cameron JM; Sala A; Antoniou G; Brennan PM; Butler HJ; Conn JJA; Connal S; Curran T; Hegarty MG; McHardy RG; Orringer D; Palmer DS; Smith BR; Baker MJ
    Br J Cancer; 2023 Nov; 129(10):1658-1666. PubMed ID: 37717120
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Untargeted LC-HRMS-Based Metabolomics for Searching New Biomarkers of Pancreatic Ductal Adenocarcinoma: A Pilot Study.
    Ríos Peces S; Díaz Navarro C; Márquez López C; Caba O; Jiménez-Luna C; Melguizo C; Prados JC; Genilloud O; Vicente Pérez F; Pérez Del Palacio J
    SLAS Discov; 2017 Apr; 22(4):348-359. PubMed ID: 27655283
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating tumor cells as a "real-time liquid biopsy": Recent advances and the application in ovarian cancer.
    Jou HJ; Ling PY; Hsu HT
    Taiwan J Obstet Gynecol; 2022 Jan; 61(1):34-39. PubMed ID: 35181043
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Delivering on the promise of early detection with liquid biopsies.
    Crosby D
    Br J Cancer; 2022 Feb; 126(3):313-315. PubMed ID: 35013576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Highly accurate detection of ovarian cancer using CA125 but limited improvement with serum matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling.
    Tiss A; Timms JF; Smith C; Devetyarov D; Gentry-Maharaj A; Camuzeaux S; Burford B; Nouretdinov I; Ford J; Luo Z; Jacobs I; Menon U; Gammerman A; Cramer R
    Int J Gynecol Cancer; 2010 Dec; 20(9):1518-24. PubMed ID: 21370595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor Biomarker In-Solution Quantification, Standard Production, and Multiplex Detection.
    Japp NC; Souchek JJ; Sasson AR; Hollingsworth MA; Batra SK; Junker WM
    J Immunol Res; 2021; 2021():9942605. PubMed ID: 34514003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Refining Cancer Management Using Integrated Liquid Biopsy.
    Qiu J; Xu J; Zhang K; Gu W; Nie L; Wang G; Luo Y
    Theranostics; 2020; 10(5):2374-2384. PubMed ID: 32089746
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum biomarker panels for the detection of pancreatic cancer.
    Brand RE; Nolen BM; Zeh HJ; Allen PJ; Eloubeidi MA; Goldberg M; Elton E; Arnoletti JP; Christein JD; Vickers SM; Langmead CJ; Landsittel DP; Whitcomb DC; Grizzle WE; Lokshin AE
    Clin Cancer Res; 2011 Feb; 17(4):805-16. PubMed ID: 21325298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study.
    Nakamura K; Zhu Z; Roy S; Jun E; Han H; Munoz RM; Nishiwada S; Sharma G; Cridebring D; Zenhausern F; Kim S; Roe DJ; Darabi S; Han IW; Evans DB; Yamada S; Demeure MJ; Becerra C; Celinski SA; Borazanci E; Tsai S; Kodera Y; Park JO; Bolton JS; Wang X; Kim SC; Von Hoff D; Goel A
    Gastroenterology; 2022 Nov; 163(5):1252-1266.e2. PubMed ID: 35850192
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic accuracy of cerebrospinal fluid and serum-isolated extracellular vesicles for glioblastoma: a systematic review and meta-analysis.
    Jafari D; Tiyuri A; Rezaei E; Moradi Y; Jafari R; Jokar Shoorijeh F; Barati M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1075-1085. PubMed ID: 33131342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent Progress on Liquid Biopsy Analysis using Surface-Enhanced Raman Spectroscopy.
    Zhang Y; Mi X; Tan X; Xiang R
    Theranostics; 2019; 9(2):491-525. PubMed ID: 30809289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deep cfDNA fragment end profiling enables cancer detection.
    Zhitnyuk YV; Koval AP; Alferov AA; Shtykova YA; Mamedov IZ; Kushlinskii NE; Chudakov DM; Shcherbo DS
    Mol Cancer; 2022 Jan; 21(1):26. PubMed ID: 35062943
    [No Abstract]   [Full Text] [Related]  

  • 53. Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA.
    Lee JS; Park SS; Lee YK; Norton JA; Jeffrey SS
    Mol Oncol; 2019 Aug; 13(8):1623-1650. PubMed ID: 31243883
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Liquid Biopsy for Pancreatic Cancer Detection Using Infrared Spectroscopy.
    Sala A; Cameron JM; Jenkins CA; Barr H; Christie L; Conn JJA; Evans TRJ; Harris DA; Palmer DS; Rinaldi C; Theakstone AG; Baker MJ
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804820
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cationic Conjugated Polymer/Hyaluronan-Doxorubicin Complex for Sensitive Fluorescence Detection of Hyaluronidase and Tumor-Targeting Drug Delivery and Imaging.
    Huang Y; Song C; Li H; Zhang R; Jiang R; Liu X; Zhang G; Fan Q; Wang L; Huang W
    ACS Appl Mater Interfaces; 2015 Sep; 7(38):21529-37. PubMed ID: 26331442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum fibrinogen as a diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma.
    Chung KH; Lee JC; Lee J; Cho IK; Kim J; Jang W; Yoo BC; Hwang JH
    Pancreatology; 2020 Oct; 20(7):1465-1471. PubMed ID: 32873483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extracellular Vesicles in Cancer Detection: Hopes and Hypes.
    Hu T; Wolfram J; Srivastava S
    Trends Cancer; 2021 Feb; 7(2):122-133. PubMed ID: 33008796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum N-Glycome analysis reveals pancreatic cancer disease signatures.
    Vreeker GCM; Hanna-Sawires RG; Mohammed Y; Bladergroen MR; Nicolardi S; Dotz V; Nouta J; Bonsing BA; Mesker WE; van der Burgt YEM; Wuhrer M; Tollenaar RAEM
    Cancer Med; 2020 Nov; 9(22):8519-8529. PubMed ID: 32898301
    [TBL] [Abstract][Full Text] [Related]  

  • 59. RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer.
    Hulstaert E; Levanon K; Morlion A; Van Aelst S; Christidis AA; Zamar R; Anckaert J; Verniers K; Bahar-Shany K; Sapoznik S; Vandesompele J; Mestdagh P
    Neoplasia; 2022 Feb; 24(2):155-164. PubMed ID: 34998206
    [TBL] [Abstract][Full Text] [Related]  

  • 60. EGFR mutation testing on plasma and urine samples: A pilot study evaluating the value of liquid biopsy in lung cancer diagnosis and management.
    Satapathy S; Singh V; Nambirajan A; Malik PS; Tanwar P; Mehta A; Suryavanshi M; Thulkar S; Mohan A; Jain D
    Curr Probl Cancer; 2021 Dec; 45(6):100722. PubMed ID: 33712318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.